The Electrospinning Company

What The Electrospinning Company does

The Electrospinning Company is a UK-based contract development and manufacturing organisation (CDMO) founded in 2010 as a spin-out from the UK Science and Technology Facilities Council (STFC), headquartered at Harwell Campus, Oxfordshire. The company develops and manufactures electrospun nanofiber biomaterials and coatings for medical device manufacturers, operating from ISO Class 7 cleanrooms under ISO 13485 certification held since 2015. It serves customers across cardiovascular, orthopaedic and sports medicine, wound healing and soft tissue regeneration, and ophthalmology applications; its components are currently incorporated into five FDA 510(k)-cleared medical devices, with three internationally marketed products having treated more than 10,000 patients to date.

The company's core offering is built on electrospinning technology that uses high-voltage electrical forces to transform viscous polymer solutions into ultra-fine fibres replicating the extracellular matrix. It has packaged this capability into four proprietary platforms: Caladrix (low-profile device coatings for stents, valves, and occlusion devices), Symatix (biosynthetic materials combining natural compounds such as collagen, hyaluronic acid, and chitosan with synthetic fibres), Mimetix (resorbable scaffolds for tissue regeneration with controlled degradation), and Kalyptix (permanent implants for long-term integration). The platform portfolio is protected by issued UK and European patents and underpinned by more than a decade of process know-how and 80+ completed development studies.

The company operates a fee-for-service CDMO model, generating revenue through contract design, development, and manufacturing engagements, with supplementary proprietary material out-licensing opportunities. Customer acquisition is driven by direct enterprise sales, technical consultations, conference presence at major medtech events, and a channel partnership with Avem Market Solutions covering Europe, the USA, and the Middle East. Strategic partnerships with Confluent Medical Technologies (lead investor and board representation since May 2021), Bioinicia Fluidnatek (electrospinning equipment and process development since 2017), Relisys Medical Devices (Indian cardiovascular market access since September 2023), and DSM-Firmenich (advanced materials collaboration reinforced February 2026) anchor both the commercial and technical growth path.

Name

The Electrospinning Company

Legal name

The Electrospinning Company Ltd

Website

https://electrospinning.co.uk

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

11–50 employees

Short description

The Electrospinning Company is a UK-based CDMO developing and manufacturing electrospun nanofiber biomaterials and coatings for medical device manufacturers serving cardiovascular, orthopaedic, wound healing, and ophthalmology applications, with components in five FDA-cleared devices.

Ownership category

akta.pro rank

Headquarters

HQ city

Oxton

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Infrastructure, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. Contract Development and Manufacturing Services (CDMO): The company generates revenue by offering fee-for-service contract design, development, and manufacturing of electrospun biomaterials and coatings for medical device manufacturers. Revenues are growing rapidly year-on-year. The company also develops proprietary materials for targeted out-licensing opportunities.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

The Electrospinning Company operates as a contract development and manufacturing organisation (CDMO) that designs, develops, and manufactures medical-grade electrospun biomaterials and coatings for medical device manufacturers. The company offers four proprietary technology platforms (Caladrix®, Symatix®, Mimetix®, Kalyptix®) and provides end-to-end services from feasibility studies through commercial-scale manufacturing in ISO Class 7 cleanrooms under ISO 13485 certification.

Product overview

The Electrospinning Company offers a portfolio of four proprietary technology platforms—Caladrix®, Symatix®, Mimetix®, and Kalyptix®—built on a core electrospinning technology that transforms polymer solutions into ultra-fine nanofibrous materials mimicking the extracellular matrix. These platforms are differentiated by material type: Caladrix provides low-profile coatings and coverings for cardiovascular and implantable devices; Symatix combines synthetic fibers with natural polymers (collagen, hyaluronic acid, chitosan) for biosynthetic applications; Mimetix delivers resorbable scaffolds for tissue regeneration; and Kalyptix offers permanent implants for long-term integration. The company operates as a contract development and manufacturing organization (CDMO), providing services from feasibility through scale-up manufacturing in ISO Class VII cleanrooms.

Differentiator

Problem solved

Functional benefit

Brands

• Caladrix®: Advanced device coverings with superior adhesion for stents, valves, and occlusion devices. Low-profile electrospun coatings and coverings for minimally invasive medical devices.
• Symatix®
• Mimetix®
• Kalyptix®

Products and services

• Caladrix® Low-profile electrospun coatings and coverings for stents, valves, frames, occlusion devices, and other minimally invasive medical implants. Provides superior adhesion, permeability control, flexibility, and tissue interaction for cardiovascular and structural heart devices.
• Symatix® Biosynthetic materials combining natural compounds (collagen, hyaluronic acid, chitosan) with synthetic electrospun fibers in a one-step process for enhanced biocompatibility, fluid interaction, and biological contact in medical devices.
• Mimetix® Resorbable electrospun scaffolds supporting tissue regeneration with controlled degradation profiles aligned to tissue healing timelines. Designed for soft tissue integration and scalable manufacturing.
• Kalyptix® Permanent, non-woven electrospun materials designed for long-term implantation. Engineered for tissue integration, stability, and durable device performance in cardiovascular, oral/maxillofacial, and cell therapy applications.
• Contract Development & Manufacturing Services (CDMO) End-to-end services from feasibility studies through commercial-scale manufacturing, including product development, process development, process validation, and clinical-grade manufacturing in ISO Class 7 cleanrooms under ISO 13485 guidelines for medical device manufacturers.

Quantifiable outcome

• Over 10,000 patients treated with devices containing the company's electrospun components across three internationally marketed products
• +3 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Four partnerships are on record, tiered minor and core.

• DSM-FirmenichminorStrategic or Co-development Partner · 23 February 2026Long-standing strategic partnership with DSM-Firmenich focused on advanced materials collaboration. Representatives from DSM visited The Electrospinning Company's facilities in February 2026 to reinforce the relationship and further strengthen the strategic partnership, combining complementary expertise in advanced materials and electrospinning technologies.
• Avem Market SolutionscoreChannel Partner/ Reseller/ Distributor · 7 November 2024Strategic partnership announced in November 2024 where Avem Market Solutions represents The Electrospinning Company's advanced biomaterials to medical device manufacturers across Europe, USA, and the Middle East. Avem brings technical sales experience and deep industry knowledge to accelerate commercialisation.
• Relisys Medical DevicescoreStrategic or Co-development Partner · 1 September 2023In September 2023, UK-based The Electrospinning Company partnered with India-based Relisys Medical Devices to develop cardiovascular medical devices using The Electrospinning Company's Caladrix technology. The partnership focused on creating advanced device coverings and coatings for cardiovascular applications.
• Bioinicia FluidnatekcoreTechnology or Integration · 7 July 2023Partnership with Bioinicia Fluidnatek (operating since 2017) using FLUIDNATEK electrospinning and electrospraying equipment platform for biomaterial development and custom design, development, and manufacturing services. The collaboration includes continual improvement projects, development of automated production processes, and use of the BioTubing platform for electrospun tubular structures for structural heart and peripheral vascular interventions.

Scale indicators8 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Zeus Industrial Products: Polymer-based CDMO supplying tubing, coatings, and biomaterial components to medical device OEMs across cardiovascular, neurovascular, and general surgery. Comparable as a polymer and biomaterial component CDMO serving the same regulated medical device supply chain.
• Secant Group (Poly-Med): Medical textile and biomaterials CDMO producing woven, knitted, braided, and electrospun structures for implantable devices. Direct peer in contract-manufactured electrospun and textile biomaterials for cardiovascular, orthopaedic, and tissue-engineering applications.
• Putnam Plastics (part of Contec Medical): Medical polymer CDMO producing custom extrusions, tubing, and braided/coated shafts for catheter-delivered devices. Directly comparable as a CDMO for minimally invasive cardiovascular and structural heart devices, the same end-application segment Electrospinning's Caladrix platform targets.
• Confluent Medical Technologies: US-headquartered CDMO specialising in materials science for implantable products such as valves, grafts, and catheters. Directly comparable as a medical device CDMO serving the same cardiovascular OEM customer base; also Electrospinning's lead strategic investor and Board seat holder, providing direct insight into the competitive overlap.
• Bioinicia Fluidnatek: Provider of FLUIDNATEK electrospinning and electrospraying equipment and contract manufacturing services for biomaterials. Direct peer in electrospun biomaterial CDMO services and Electrospinning's equipment/development partner since 2017.

Broad incumbents

• Trelleborg Healthcare & Medical: Polymer-engineering CDMO manufacturing precision silicone, elastomer, and polymer components for medical devices including drug-device combination products. Comparable as a larger contract manufacturer of advanced polymer components for medical device OEMs.
• Evonik Health Care: Specialty chemicals and materials division offering bioresorbable polymers, excipients, and contract manufacturing for medical devices and pharma. Comparable as a larger incumbent supplying advanced biomaterials to the same implantable device and tissue-engineering customer base.
• DSM Biomedical (DSM-Firmenich): Global biomedical materials supplier and CDMO offering polymers, coatings, and regenerative-materials platforms for medical devices. Direct strategic partner of Electrospinning; comparable as a much larger incumbent serving the same implantable device customer base.
• Integra LifeSciences: Public medical device company with a dedicated regenerative technologies portfolio including dural repair, wound care, and orthobiologic scaffolds. Comparable incumbent in the same neurosurgical (dural repair), wound-healing, and soft-tissue regeneration end markets where Electrospinning's Mimetix and Symatix platforms are positioned.

Emerging players

• Collagen Solutions (Rousselot): Biomaterial CDMO focused on collagen-based medical device components and tissue-engineering scaffolds. Comparable as a contract supplier of natural-polymer biomaterials to medical device manufacturers, intersecting with Electrospinning's Symatix biosynthetic platform.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/the-electrospinning-company-ltd.
• Xx.com/electrospinner

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds6 records

Investors11 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The Electrospinning Company